Skip to main content
About Us
Image Credits
Contributor Info
RSS
Log In
Join
Twitter
E-Alerts
Visit StemJournal
Main menu
About
Image Credits
Contributor Info
E-Alerts
Chapters
Cellular and nuclear reprogramming
Ectoderm specification and differentiation
Endoderm specification and differentiation
Epigenetics
Genomics and proteomics
Germ cell and somatic stem cell biology in reproduction
Manufacturing
Mesoderm specification and differentiation
Niche biology, homing, and migration
Renewal
Stem cell immunology
Therapeutic prospects
Tissue engineering
Protocols
Ectoderm differentiation
Endoderm differentiation
Genome editing
Mesoderm differentiation
Pluripotent stem cells
PSC characterization
PSC genetic stability
Reprogramming
StemLabs
Stem Cell COREdinates
Core Facility Profiles
Boston Children's Hospital Human Neuron Core
Boston University Center for Regenerative Medicine iPSC Core
Columbia Stem Cell Initiative Stem Cell Core Facility
Harvard Stem Cell Institute iPS Core Facility
Stem Cell Protocols
Stem Cell Reagents
Other Resources
News & Profiles
Latest News
Stem Cell Institute Profiles
Journal Stream
Forum
Search form
Search
You are here
Home
Biblio
Author
Title
Type
[
Year
]
Filters:
Author
is
Dimopoulos, Meletios-Athanasios
[Clear All Filters]
2023
Sonneveld P
,
Richardson PG
,
Ludwig H
,
Dimopoulos M-A
,
Schjesvold FH
,
Hajek R
,
Abdulhaq H
,
Thuresson M
,
Norin S
,
Bakker NA
, et al.
Benefit Versus Risk Assessment of Melflufen and Dexamethasone in Relapsed/Refractory Multiple Myeloma: Analyses From Longer Follow-up of the OCEAN and HORIZON Studies.
Clin Lymphoma Myeloma Leuk. 2023.
PubMed
Google Scholar
Papaiakovou EEleutherak
,
Terpos E
,
Kanellias N
,
Migkou M
,
Gavriatopoulou M
,
Ntanasis-Stathopoulos I
,
Fotiou D
,
Malandrakis P
,
Theodorakakou F
,
Spiliopoulou V
, et al.
Impact of daratumumab on stem cell mobilization and collection, engraftment and early post-transplant complications among multiple myeloma patients undergoing autologous stem cell transplantation.
Leuk Lymphoma. 2023:1-8.
PubMed
Google Scholar
Katodritou E
,
Kastritis E
,
Dalampira D
,
Delimpasi S
,
Spanoudakis E
,
Labropoulou V
,
Ntanasis-Stathopoulos I
,
Gkioka A-I
,
Giannakoulas N
,
Kanellias N
, et al.
Improved Survival of Patients with Primary Plasma Cell Leukemia with VRd or Daratumumab-based Quadruplets: A Multicenter Study by the Greek Myeloma Study Group.
Am J Hematol. 2023.
PubMed
Google Scholar
2022
Schjesvold FH
,
Dimopoulos M-A
,
Delimpasi S
,
Robak P
,
Coriu D
,
Legiec W
,
Pour L
,
Spicka I
,
Masszi T
,
Doronin V
, et al.
Melflufen or pomalidomide plus dexamethasone for patients with multiple myeloma refractory to lenalidomide (OCEAN): a randomised, head-to-head, open-label, phase 3 study.
Lancet Haematol. 2022.
PubMed
Google Scholar